|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.19 USD | -2.25% |
|
-8.35% | -33.28% |
| 17/07 | EyePoint Pharmaceuticals Agrees to Settle US False Claims Act Allegations | MT |
| 16/07 | Stifel Initiates EyePoint Pharmaceuticals at Buy With $40 Price Target | MT |
| Market Cap | 102.2Cr 90Cr 83Cr 77Cr 143.93Cr 9.84TCr 146.15Cr 991.29Cr 387.29Cr 4.84TCr 383.67Cr 375.4Cr 17TCr | P/E 2026 * |
-3.42x | P/E 2027 * | -4.1x |
|---|---|---|---|---|---|
| Enterprise Value | 73Cr 64Cr 59Cr 55Cr 102.48Cr 7.01TCr 104.06Cr 705.8Cr 275.75Cr 3.45TCr 273.17Cr 267.29Cr 12TCr | EV / Sales 2026 * |
415x | EV / Sales 2027 * | 26.2x |
| Free-Float |
96.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: EyePoint, Inc.
| 1 day | -2.25% | ||
| 1 week | -8.35% | ||
| Current month | -14.76% | ||
| 1 month | -11.09% | ||
| 3 months | -11.47% | ||
| 6 months | -19.70% | ||
| Current year | -33.28% |
| 1 week | 12.06 |  | 13.79 |
| 1 month | 12.06 | | 15.92 |
| Current year | 11.3 | | 18.87 |
| 1 year | 9.4 | | 19.11 |
| 3 years | 3.91 | | 30.99 |
| 5 years | 2.19 | | 30.99 |
| 10 years | 2.19 | | 42.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 67 | 10/07/2023 |
George Elston
DFI | Director of Finance/CFO | 61 | 14/11/2019 |
Ramiro Ribeiro
CTO | Chief Tech/Sci/R&D Officer | 43 | 04/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jay Duker
BRD | Director/Board Member | 67 | 10/07/2023 |
Fred Hassan
BRD | Director/Board Member | 80 | 03/09/2024 |
Wendy DiCicco
BRD | Director/Board Member | 58 | 15/07/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Fiscal year | Chief Executive Officer | 41,393 | 0.0494% | ||
| 30/06/26 | Fiscal year | Chief Technology Officer | 14,625 | 0.0174% | ||
| 25/05/26 | Fiscal year | Chief Financial Officer | 18,627 | 0.0222% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.25% | -8.35% | +16.32% | +12.35% | 102.2Cr | |
| +0.86% | +1.43% | +47.17% | +161.40% | 1,06700Cr | |
| +1.59% | +4.09% | +56.51% | +52.79% | 63TCr | |
| +0.95% | +1.91% | +36.30% | +83.13% | 46TCr | |
| +1.60% | +6.25% | +37.00% | +30.00% | 35TCr | |
| -0.60% | +1.52% | +36.67% | +39.80% | 30TCr | |
| -0.14% | +0.60% | +17.29% | +18.19% | 26TCr | |
| +0.09% | -2.82% | -29.09% | -41.29% | 22TCr | |
| +1.22% | +2.66% | +22.66% | +59.81% | 20TCr | |
| -1.18% | -3.70% | +11.28% | +67.43% | 16TCr | |
| Average | +0.21% | +0.36% | +25.21% | +48.36% | 36.45TCr | |
| Weighted average by Cap. | +0.76% | +1.95% | +35.99% | +78.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17.52L 15.38L 14.31L 13.13L 24.67L 17Cr 25.05L 1.7Cr 66.38L 8.29Cr 65.76L 64.34L 29Cr | 3.28Cr 2.88Cr 2.68Cr 2.46Cr 4.61Cr 315.45Cr 4.68Cr 32Cr 12Cr 155.09Cr 12Cr 12Cr 536.22Cr |
| Net income | -32Cr -28Cr -26Cr -24Cr -45Cr -3.04TCr -45Cr -306.65Cr -119.8Cr -1.5TCr -118.68Cr -116.13Cr -5.18TCr | -29Cr -25Cr -24Cr -22Cr -41Cr -2.78TCr -41Cr -280.46Cr -109.57Cr -1.37TCr -108.55Cr -106.21Cr -4.73TCr |
| Net Debt | -29Cr -26Cr -24Cr -22Cr -41Cr -2.83TCr -42Cr -285.49Cr -111.54Cr -1.39TCr -110.49Cr -108.11Cr -4.82TCr | -16Cr -14Cr -13Cr -12Cr -23Cr -1.58TCr -23Cr -158.68Cr -62Cr -774.58Cr -61Cr -60Cr -2.68TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $12.19 | -2.25% | 14,68,697 |
| 23/26/23 | $12.47 | -1.50% | 12,84,723 |
| 22/26/22 | $12.66 | -2.99% | 10,63,990 |
| 21/26/21 | $13.05 | +3.08% | 15,85,308 |
| 20/26/20 | $12.66 | -4.81% | 10,99,731 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EYPT Stock
Select your edition
All financial news and data tailored to specific country editions
